name nAnno nOverlap fc zscore pvalue adjp or CIl CIu
MP:0013258 abnormal extracellular matrix morphology 52 9 16.7 11.6 2.4e-09 1.3e-06 22 9.12 47.5
MP:0001614 abnormal blood vessel morphology 1178 35 2.87 7.03 2.1e-09 1.3e-06 4.04 2.57 6.25
MP:0002128 abnormal blood circulation 719 26 3.5 7.12 9.4e-09 3.2e-06 4.55 2.76 7.28
MP:0002127 abnormal cardiovascular system morphology 1950 45 2.23 6.25 1.2e-08 3.2e-06 3.37 2.2 5.15
MP:0003231 abnormal placenta vasculature 142 12 8.17 8.8 2.2e-08 3.8e-06 9.94 4.82 18.9
MP:0001711 abnormal placenta morphology 356 18 4.89 7.65 1.9e-08 3.8e-06 6.04 3.36 10.3
MP:0001544 abnormal cardiovascular system physiology 1571 39 2.4 6.22 2.9e-08 4.5e-06 3.42 2.2 5.25
MP:0002086 abnormal extraembryonic tissue morphology 663 24 3.5 6.83 4e-08 5.3e-06 4.46 2.66 7.22
MP:0002828 abnormal renal glomerular capsule morphology 124 11 8.57 8.68 5.2e-08 6.2e-06 10.4 4.86 20.2
MP:0001914 hemorrhage 582 22 3.65 6.76 7.8e-08 8.3e-06 4.58 2.69 7.52
MP:0004272 abnormal basement membrane morphology 45 7 15 9.65 3.3e-07 3.3e-05 18.9 6.93 44.4
MP:0001716 abnormal placenta labyrinth morphology 187 12 6.2 7.35 4.5e-07 4e-05 7.35 3.59 13.8
MP:0006207 embryonic lethality during organogenesis 942 27 2.77 5.86 5.7e-07 4.7e-05 3.54 2.17 5.62
MP:0006208 lethality throughout fetal growth and development 504 19 3.64 6.24 7.4e-07 5.6e-05 4.42 2.51 7.46
MP:0004196 abnormal prenatal growth/weight/body size 1147 30 2.53 5.65 7.9e-07 5.6e-05 3.28 2.05 5.15
MP:0002088 abnormal embryonic growth/weight/body size 966 27 2.7 5.71 9.5e-07 6.3e-05 3.43 2.1 5.46
MP:0003658 abnormal capillary morphology 106 9 8.21 7.63 1.3e-06 7.8e-05 9.68 4.16 20
MP:0011090 perinatal lethality, incomplete penetrance 332 15 4.37 6.39 1.4e-06 7.8e-05 5.18 2.74 9.18
MP:0005391 vision/eye phenotype 1518 35 2.23 5.35 1.4e-06 7.8e-05 2.98 1.9 4.61
MP:0011497 abnormal glomerular capsule visceral layer morphology 82 8 9.43 7.84 1.9e-06 9e-05 11.2 4.52 24.2
MP:0005326 abnormal podocyte morphology 82 8 9.43 7.84 1.9e-06 9e-05 11.2 4.52 24.2
MP:0002081 perinatal lethality 1327 32 2.33 5.35 1.8e-06 9e-05 3.05 1.92 4.75
MP:0002925 abnormal cardiovascular development 766 23 2.9 5.62 2.3e-06 0.00011 3.58 2.12 5.83
MP:0010866 abnormal prenatal body size 862 24 2.69 5.33 4.9e-06 0.00022 3.32 1.99 5.37
MP:0002116 abnormal craniofacial bone morphology 693 21 2.93 5.4 6e-06 0.00026 3.55 2.06 5.86
MP:0002092 abnormal eye morphology 1412 32 2.19 4.97 7e-06 0.00029 2.83 1.78 4.4
MP:0008803 abnormal placental labyrinth vasculature morphology 99 8 7.81 6.97 7.7e-06 0.00031 9.08 3.69 19.4
MP:0003566 abnormal cell adhesion 72 7 9.4 7.31 8.7e-06 0.00032 11 4.15 25
MP:0003881 abnormal nephron morphology 487 17 3.37 5.5 8.7e-06 0.00032 3.99 2.19 6.86
MP:0003070 increased vascular permeability 51 6 11.4 7.59 1.3e-05 0.00045 13.5 4.6 32.9
MP:0002827 abnormal renal corpuscle morphology 350 14 3.87 5.59 1.3e-05 0.00045 4.49 2.33 8.08
MP:0000438 abnormal cranium morphology 679 20 2.85 5.11 1.6e-05 0.00053 3.4 1.96 5.67
MP:0003279 aneurysm 54 6 10.7 7.34 1.8e-05 0.00058 12.7 4.32 30.7
MP:0011348 abnormal renal glomerulus basement membrane morphology 55 6 10.5 7.26 2e-05 0.00058 12.4 4.24 30
MP:0005264 glomerulosclerosis 81 7 8.35 6.8 1.9e-05 0.00058 9.67 3.66 21.8
MP:0011108 embryonic lethality during organogenesis, incomplete penetrance 315 13 3.99 5.52 2e-05 0.00058 4.6 2.33 8.43
MP:0005294 abnormal heart ventricle morphology 686 20 2.82 5.06 1.8e-05 0.00058 3.36 1.93 5.61
MP:0002152 abnormal brain morphology 1633 34 2.01 4.61 2.1e-05 0.00058 2.6 1.65 4.03
MP:0000523 cortical renal glomerulopathies 190 10 5.09 5.82 2.5e-05 0.00065 5.81 2.65 11.5
MP:0001784 abnormal fluid regulation 761 21 2.67 4.91 2.5e-05 0.00065 3.19 1.86 5.28
MP:0005380 embryo phenotype 1722 35 1.96 4.53 2.5e-05 0.00065 2.55 1.63 3.94
MP:0002703 abnormal renal tubule morphology 277 12 4.19 5.51 2.6e-05 0.00066 4.81 2.36 8.98
MP:0001634 internal hemorrhage 324 13 3.88 5.39 2.7e-05 0.00066 4.47 2.26 8.17
MP:0001697 abnormal embryo size 709 20 2.73 4.89 3e-05 0.00072 3.24 1.86 5.4
MP:0000521 abnormal kidney cortex morphology 378 14 3.58 5.24 3.1e-05 0.00073 4.14 2.14 7.43
MP:0001785 edema 483 16 3.2 5.08 3.2e-05 0.00073 3.73 2.02 6.5
MP:0012082 delayed heart development 19 4 20.3 8.63 3.7e-05 0.00084 26.5 6.29 85.3
MP:0002191 abnormal artery morphology 491 16 3.15 5 3.8e-05 0.00086 3.67 1.98 6.38
MP:0002705 dilated renal tubules 125 8 6.19 5.97 4.3e-05 0.00088 7.04 2.88 14.9
MP:0001698 decreased embryo size 608 18 2.86 4.85 4.3e-05 0.00088 3.36 1.88 5.71
MP:0011086 postnatal lethality, incomplete penetrance 786 21 2.58 4.74 4.1e-05 0.00088 3.08 1.79 5.09
MP:0002058 neonatal lethality 979 24 2.37 4.63 4.1e-05 0.00088 2.87 1.72 4.64
MP:0011409 increased renal glomerulus basement membrane thickness 40 5 12.1 7.18 5.3e-05 0.00099 14.3 4.29 37.9
MP:0003606 kidney failure 65 6 8.92 6.55 5.3e-05 0.00099 10.3 3.54 24.6
MP:0008059 abnormal podocyte foot process morphology 65 6 8.92 6.55 5.3e-05 0.00099 10.3 3.54 24.6
MP:0003984 embryonic growth retardation 560 17 2.93 4.83 5.2e-05 0.00099 3.42 1.89 5.88
MP:0014134 abnormal embryo morphology 1333 29 2.1 4.45 4.9e-05 0.00099 2.61 1.62 4.12
MP:0002109 abnormal limb morphology 806 21 2.52 4.61 5.9e-05 0.0011 3 1.74 4.94
MP:0011349 abnormal renal glomerulus basement membrane thickness 43 5 11.2 6.88 7.5e-05 0.0013 13.2 3.97 34.7
MP:0003634 abnormal glial cell morphology 409 14 3.31 4.88 7.3e-05 0.0013 3.8 1.97 6.82
MP:0011439 abnormal kidney cell proliferation 45 5 10.7 6.7 9.4e-05 0.0015 12.5 3.78 32.9
MP:0011402 renal cast 45 5 10.7 6.7 9.4e-05 0.0015 12.5 3.78 32.9
MP:0011655 abnormal systemic artery morphology 268 11 3.97 5.04 9.5e-05 0.0015 4.49 2.14 8.58
MP:0000259 abnormal vascular development 528 16 2.93 4.67 9.2e-05 0.0015 3.39 1.83 5.89
MP:0000452 abnormal mouth morphology 529 16 2.92 4.66 9.4e-05 0.0015 3.38 1.83 5.88
MP:0002108 abnormal muscle morphology 963 23 2.31 4.39 9.4e-05 0.0015 2.76 1.64 4.49
MP:0000428 abnormal craniofacial morphology 1095 25 2.21 4.35 8.9e-05 0.0015 2.67 1.61 4.29
MP:0005382 craniofacial phenotype 1099 25 2.2 4.33 9.5e-05 0.0015 2.66 1.61 4.27
MP:0005265 abnormal blood urea nitrogen level 225 10 4.3 5.12 1e-04 0.0016 4.85 2.21 9.53
MP:0001695 abnormal gastrulation 369 13 3.41 4.82 1e-04 0.0016 3.88 1.97 7.09
MP:0005325 abnormal renal glomerulus morphology 321 12 3.61 4.87 0.00011 0.0017 4.1 2.02 7.65
MP:0001619 abnormal vascular permeability 75 6 7.73 5.99 0.00012 0.0018 8.8 3.04 20.9
MP:0000260 abnormal angiogenesis 375 13 3.35 4.75 0.00012 0.0018 3.82 1.93 6.97
MP:0013658 abnormal myeloid cell morphology 1702 33 1.87 4.08 0.00013 0.0018 2.36 1.49 3.66
MP:0005623 abnormal meninges morphology 26 4 14.9 7.24 0.00014 0.0019 18.1 4.44 54.8
MP:0012501 abnormal pericardial cavity morphology 147 8 5.26 5.32 0.00013 0.0019 5.91 2.43 12.5
MP:0000272 abnormal aorta morphology 232 10 4.17 4.99 0.00014 0.0019 4.69 2.14 9.21
MP:0002135 abnormal kidney morphology 858 21 2.37 4.29 0.00014 0.002 2.79 1.63 4.61
MP:0000516 abnormal renal/urinary system morphology 927 22 2.29 4.25 0.00015 0.002 2.72 1.6 4.45
MP:0002113 abnormal skeleton development 496 15 2.92 4.5 0.00016 0.0021 3.35 1.78 5.91
MP:0001106 abnormal Schwann cell morphology 51 5 9.48 6.21 0.00017 0.0022 10.9 3.3 28.2
MP:0000454 abnormal jaw morphology 442 14 3.06 4.54 0.00017 0.0022 3.49 1.81 6.26
MP:0001105 abnormal PNS glial cell morphology 52 5 9.29 6.13 0.00019 0.0024 10.7 3.24 27.6
MP:0003044 impaired basement membrane formation 12 3 24.2 8.21 0.00022 0.0026 32.8 5.62 134
MP:0006271 abnormal involution of the mammary gland 29 4 13.3 6.8 0.00021 0.0026 15.9 3.94 47.4
MP:0002725 abnormal vein morphology 118 7 5.73 5.29 0.00021 0.0026 6.42 2.45 14.2
MP:0011109 lethality throughout fetal growth and development, incomplete penetrance 247 10 3.91 4.74 0.00023 0.0026 4.39 2.01 8.61
MP:0000771 abnormal brain size 343 12 3.38 4.6 2e-04 0.0026 3.82 1.88 7.12
MP:0011098 embryonic lethality during organogenesis, complete penetrance 751 19 2.45 4.22 0.00021 0.0026 2.85 1.62 4.79
MP:0001672 abnormal embryo development 1018 23 2.18 4.09 0.00022 0.0026 2.59 1.54 4.21
MP:0002083 premature death 1443 29 1.94 3.98 0.00021 0.0026 2.38 1.48 3.74
MP:0008762 embryonic lethality 1763 33 1.81 3.86 0.00025 0.0029 2.26 1.43 3.5
MP:0005371 limbs/digits/tail phenotype 1030 23 2.16 4.03 0.00026 0.003 2.56 1.52 4.16
MP:0000066 osteoporosis 56 5 8.63 5.86 0.00027 0.0031 9.83 2.99 25.3
MP:0006042 increased apoptosis 832 20 2.32 4.09 0.00027 0.0031 2.71 1.56 4.51
MP:0000288 abnormal pericardium morphology 255 10 3.79 4.62 0.00029 0.0032 4.24 1.94 8.31
MP:0000249 abnormal blood vessel physiology 410 13 3.06 4.37 0.00029 0.0032 3.47 1.76 6.32
MP:0010865 prenatal growth retardation 644 17 2.55 4.17 0.00029 0.0032 2.94 1.62 5.04
MP:0012556 increased cell death 837 20 2.31 4.06 0.00029 0.0032 2.69 1.55 4.48
MP:0003675 kidney cysts 166 8 4.66 4.86 0.00031 0.0033 5.19 2.14 10.9
MP:0002932 abnormal joint morphology 307 11 3.46 4.49 0.00031 0.0033 3.88 1.85 7.41
MP:0005369 muscle phenotype 1401 28 1.93 3.87 0.00031 0.0033 2.34 1.45 3.7
MP:0009768 impaired somite development 127 7 5.33 5.02 0.00033 0.0034 5.94 2.27 13.1
MP:0000913 abnormal brain development 780 19 2.35 4.04 0.00034 0.0035 2.73 1.55 4.59
MP:0000462 abnormal digestive system morphology 1053 23 2.11 3.92 0.00036 0.0036 2.49 1.48 4.05
MP:0000530 abnormal kidney blood vessel morphology 92 6 6.3 5.23 0.00037 0.0037 7.05 2.45 16.6
MP:0002084 abnormal developmental patterning 478 14 2.83 4.2 0.00037 0.0037 3.21 1.67 5.75
MP:0011320 abnormal glomerular capillary morphology 61 5 7.92 5.55 4e-04 0.0039 8.95 2.73 22.9
MP:0013662 decreased myeloid cell number 369 12 3.14 4.3 4e-04 0.0039 3.53 1.74 6.57
MP:0000534 abnormal ureter morphology 174 8 4.44 4.69 0.00042 0.004 4.94 2.03 10.4
MP:0001718 abnormal visceral yolk sac morphology 219 9 3.97 4.55 0.00042 0.004 4.42 1.93 8.94
MP:0002136 abnormal kidney physiology 425 13 2.96 4.22 0.00041 0.004 3.33 1.69 6.08
MP:0008271 abnormal bone ossification 426 13 2.95 4.21 0.00042 0.004 3.33 1.69 6.07
MP:0011441 decreased kidney cell proliferation 15 3 19.3 7.26 0.00045 0.0041 24.6 4.38 93
MP:0012253 abnormal intersomitic vessel morphology 35 4 11 6.09 0.00044 0.0041 12.8 3.22 37.3
MP:0008525 decreased cranium height 35 4 11 6.09 0.00044 0.0041 12.8 3.22 37.3
MP:0001690 failure of somite differentiation 62 5 7.79 5.49 0.00043 0.0041 8.79 2.69 22.5
MP:0011310 abnormal kidney capillary morphology 63 5 7.67 5.43 0.00047 0.0042 8.64 2.64 22.1
MP:0009489 abnormal blood vessel endothelium morphology 97 6 5.98 5.04 0.00049 0.0043 6.66 2.32 15.6
MP:0005565 increased blood urea nitrogen level 178 8 4.34 4.61 0.00049 0.0043 4.82 1.99 10.1
MP:0004720 abnormal platelet morphology 323 11 3.29 4.29 0.00048 0.0043 3.68 1.75 7.01
MP:0000267 abnormal heart development 377 12 3.08 4.21 0.00049 0.0043 3.45 1.7 6.42
MP:0004194 abnormal kidney pelvis morphology 136 7 4.97 4.77 5e-04 0.0044 5.52 2.11 12.2
MP:0004198 abnormal fetal size 225 9 3.87 4.45 0.00051 0.0044 4.29 1.87 8.68
MP:0011099 lethality throughout fetal growth and development, complete penetrance 326 11 3.26 4.25 0.00052 0.0044 3.64 1.73 6.94
MP:0011368 increased kidney apoptosis 65 5 7.44 5.32 0.00054 0.0045 8.35 2.56 21.3
MP:0000432 abnormal head morphology 875 20 2.21 3.84 0.00053 0.0045 2.56 1.48 4.26
MP:0003648 abnormal radial glial cell morphology 38 4 10.2 5.79 0.00061 0.005 11.7 2.95 33.8
MP:0004258 abnormal placenta size 101 6 5.74 4.9 6e-04 0.005 6.37 2.22 14.9
MP:0005274 abnormal viscerocranium morphology 501 14 2.7 4 6e-04 0.005 3.05 1.58 5.46
MP:0009644 uremia 231 9 3.77 4.35 0.00062 0.0051 4.17 1.82 8.44
MP:0011111 lethality during fetal growth through weaning, complete penetrance 17 3 17.1 6.77 0.00066 0.0052 21.1 3.82 77.5
MP:0000228 abnormal thrombopoiesis 17 3 17.1 6.77 0.00066 0.0052 21.1 3.82 77.5
MP:0008152 decreased diameter of femur 17 3 17.1 6.77 0.00066 0.0052 21.1 3.82 77.5
MP:0003411 abnormal vein development 39 4 9.91 5.7 0.00067 0.0053 11.4 2.87 32.7
MP:0000292 distended pericardium 68 5 7.11 5.17 0.00067 0.0053 7.95 2.44 20.2
MP:0000266 abnormal heart morphology 1397 27 1.87 3.6 7e-04 0.0054 2.23 1.37 3.54
MP:0005238 increased brain size 69 5 7 5.12 0.00071 0.0055 7.82 2.4 19.9
MP:0020137 decreased bone mineralization 40 4 9.67 5.62 0.00074 0.0057 11 2.8 31.7
MP:0005329 abnormal myocardium layer morphology 457 13 2.75 3.92 0.00081 0.0062 3.08 1.56 5.62
MP:0002706 abnormal kidney size 347 11 3.06 4.01 0.00087 0.0066 3.41 1.62 6.48
MP:0001142 abnormal vagina orifice morphology 42 4 9.21 5.45 0.00089 0.0067 10.5 2.66 29.9
MP:0013592 small thymus cortex 19 3 15.3 6.36 0.00092 0.0068 18.4 3.39 66
MP:0000711 thymus cortex hypoplasia 19 3 15.3 6.36 0.00092 0.0068 18.4 3.39 66
MP:0003179 thrombocytopenia 196 8 3.95 4.26 0.00093 0.0068 4.35 1.79 9.12
MP:0010545 abnormal heart layer morphology 465 13 2.7 3.85 0.00095 0.0068 3.02 1.53 5.51
MP:0001533 abnormal skeleton physiology 649 16 2.38 3.73 0.00093 0.0068 2.7 1.46 4.69
MP:0002085 abnormal embryonic tissue morphology 987 21 2.06 3.59 0.00096 0.0068 2.38 1.39 3.93
MP:0013657 abnormal blood cell morphology 1813 32 1.71 3.43 0.00095 0.0068 2.08 1.31 3.24
MP:0011180 abnormal hematopoietic cell number 1969 34 1.67 3.42 0.00091 0.0068 2.05 1.31 3.18
MP:0010097 abnormal retinal blood vessel morphology 43 4 8.99 5.37 0.00097 0.0069 10.2 2.59 29.1
MP:0004984 increased osteoclast cell number 75 5 6.44 4.84 0.001 0.0072 7.15 2.2 18.1
MP:0011110 preweaning lethality, incomplete penetrance 469 13 2.68 3.82 0.001 0.0072 3 1.52 5.46
MP:0002169 no abnormal phenotype detected 1901 33 1.68 3.39 0.001 0.0072 2.05 1.3 3.18
MP:0009869 abnormal descending aorta morphology 20 3 14.5 6.18 0.0011 0.0073 17.4 3.21 61.5
MP:0000208 decreased hematocrit 200 8 3.87 4.19 0.0011 0.0073 4.26 1.76 8.93
MP:0002873 normal phenotype 1906 33 1.67 3.37 0.0011 0.0073 2.04 1.3 3.17
MP:0005031 abnormal trophoblast layer morphology 155 7 4.37 4.32 0.0011 0.0074 4.8 1.84 10.5
MP:0006126 abnormal cardiac outflow tract development 156 7 4.34 4.3 0.0011 0.0076 4.77 1.83 10.5
MP:0001577 anemia 358 11 2.97 3.89 0.0011 0.0076 3.29 1.57 6.27
MP:0011367 abnormal kidney apoptosis 77 5 6.28 4.75 0.0012 0.0078 6.95 2.14 17.6
MP:0013661 abnormal myeloid cell number 538 14 2.52 3.7 0.0012 0.0079 2.82 1.47 5.05
MP:0008139 fused podocyte foot processes 21 3 13.8 6.01 0.0012 0.0081 16.4 3.04 57.7
MP:0001680 abnormal mesoderm development 78 5 6.2 4.71 0.0012 0.0081 6.85 2.11 17.3
MP:0001915 intracranial hemorrhage 116 6 5 4.43 0.0012 0.0081 5.5 1.92 12.8
MP:0004076 abnormal vitelline vascular remodeling 79 5 6.12 4.67 0.0013 0.0084 6.76 2.08 17.1
MP:0002114 abnormal axial skeleton morphology 1303 25 1.85 3.4 0.0013 0.0084 2.18 1.32 3.49
MP:0008140 podocyte foot process effacement 47 4 8.23 5.08 0.0014 0.0086 9.23 2.36 26.2
MP:0011087 neonatal lethality, complete penetrance 672 16 2.3 3.58 0.0013 0.0086 2.6 1.41 4.52
MP:0002447 abnormal erythrocyte morphology 810 18 2.15 3.5 0.0014 0.0091 2.44 1.37 4.15
MP:0004938 dilated vasculature 48 4 8.05 5.01 0.0015 0.0092 9.02 2.31 25.6
MP:0002871 albuminuria 81 5 5.97 4.59 0.0015 0.0092 6.58 2.03 16.6
MP:0001176 abnormal lung development 165 7 4.1 4.11 0.0016 0.0096 4.49 1.73 9.86
MP:0011898 abnormal platelet cell number 263 9 3.31 3.88 0.0016 0.0096 3.64 1.59 7.33
MP:0002100 abnormal tooth morphology 213 8 3.63 3.97 0.0016 0.0097 3.98 1.64 8.34
MP:0004200 decreased fetal size 216 8 3.58 3.92 0.0017 0.01 3.92 1.62 8.21
MP:0003935 abnormal craniofacial development 378 11 2.81 3.68 0.0017 0.01 3.11 1.48 5.91
MP:0005381 digestive/alimentary phenotype 1328 25 1.82 3.3 0.0017 0.01 2.13 1.29 3.42
MP:0020378 abnormal cell cytoskeleton morphology 24 3 12.1 5.56 0.0019 0.011 14.1 2.64 48.3
MP:0010225 abnormal quadriceps morphology 24 3 12.1 5.56 0.0019 0.011 14.1 2.64 48.3
MP:0001569 abnormal circulating bilirubin level 85 5 5.69 4.44 0.0018 0.011 6.25 1.93 15.7
MP:0003068 enlarged kidney 126 6 4.6 4.16 0.0019 0.011 5.03 1.76 11.7
MP:0002596 abnormal hematocrit 270 9 3.22 3.79 0.0019 0.011 3.54 1.55 7.13
MP:0006113 abnormal heart septum morphology 379 11 2.81 3.67 0.0018 0.011 3.1 1.48 5.89
MP:0002139 abnormal hepatobiliary system physiology 439 12 2.64 3.6 0.0018 0.011 2.93 1.44 5.44
MP:0001325 abnormal retina morphology 695 16 2.23 3.43 0.0019 0.011 2.5 1.36 4.35
MP:0005367 renal/urinary system phenotype 1190 23 1.87 3.28 0.0019 0.011 2.16 1.29 3.52
MP:0004818 increased skeletal muscle mass 25 3 11.6 5.43 0.0021 0.012 13.4 2.53 45.9
MP:0009403 increased variability of skeletal muscle fiber size 53 4 7.29 4.7 0.0021 0.012 8.1 2.08 22.8
MP:0010031 abnormal cranium size 89 5 5.43 4.29 0.0022 0.012 5.95 1.84 14.9
MP:0005195 abnormal posterior eye segment morphology 767 17 2.14 3.38 0.002 0.012 2.42 1.34 4.15
MP:0002864 abnormal ocular fundus morphology 703 16 2.2 3.38 0.0021 0.012 2.47 1.34 4.3
MP:0002082 postnatal lethality 1346 25 1.8 3.23 0.0021 0.012 2.1 1.27 3.36
MP:0008150 decreased diameter of long bones 26 3 11.2 5.3 0.0023 0.013 12.8 2.42 43.6
MP:0004983 abnormal osteoclast cell number 131 6 4.43 4.04 0.0023 0.013 4.83 1.69 11.2
MP:0005312 pericardial effusion 133 6 4.36 3.99 0.0025 0.013 4.75 1.67 11
MP:0005502 abnormal renal/urinary system physiology 708 16 2.18 3.35 0.0023 0.013 2.45 1.33 4.26
MP:0003743 abnormal facial morphology 708 16 2.18 3.35 0.0023 0.013 2.45 1.33 4.26
MP:0005076 abnormal cell differentiation 712 16 2.17 3.33 0.0024 0.013 2.44 1.32 4.23
MP:0001648 abnormal apoptosis 1280 24 1.81 3.2 0.0023 0.013 2.1 1.26 3.39
MP:0001689 incomplete somite formation 56 4 6.9 4.53 0.0026 0.014 7.63 1.96 21.4
MP:0001053 abnormal neuromuscular synapse morphology 93 5 5.2 4.16 0.0027 0.014 5.68 1.76 14.2
MP:0003257 abnormal abdominal wall morphology 95 5 5.09 4.09 0.003 0.015 5.55 1.72 13.9
MP:0000746 weakness 136 6 4.26 3.92 0.0028 0.015 4.64 1.63 10.8
MP:0006315 abnormal urine protein level 183 7 3.7 3.77 0.0028 0.015 4.02 1.55 8.81
MP:0004197 abnormal fetal growth/weight/body size 287 9 3.03 3.57 0.0028 0.015 3.31 1.45 6.67
MP:0000111 cleft palate 287 9 3.03 3.57 0.0028 0.015 3.31 1.45 6.67
MP:0000609 abnormal liver physiology 405 11 2.63 3.42 0.003 0.015 2.89 1.38 5.49
MP:0009250 abnormal appendicular skeleton morphology 724 16 2.14 3.25 0.0029 0.015 2.39 1.3 4.16
MP:0002752 abnormal somatic nervous system morphology 933 19 1.97 3.19 0.0029 0.015 2.23 1.27 3.75
MP:0001144 vagina atresia 29 3 10 4.96 0.0032 0.016 11.4 2.16 38
MP:0005343 increased circulating aspartate transaminase level 96 5 5.03 4.06 0.0031 0.016 5.49 1.7 13.7
MP:0003115 abnormal respiratory system development 188 7 3.6 3.68 0.0033 0.016 3.91 1.51 8.56
MP:0001688 abnormal somite development 237 8 3.26 3.61 0.0031 0.016 3.55 1.47 7.43
MP:0010402 ventricular septal defect 237 8 3.26 3.61 0.0031 0.016 3.55 1.47 7.43
MP:0001286 abnormal eye development 293 9 2.97 3.5 0.0032 0.016 3.24 1.42 6.53
MP:0013659 abnormal erythroid lineage cell morphology 869 18 2 3.17 0.0031 0.016 2.26 1.27 3.83
MP:0001051 abnormal somatic motor system morphology 98 5 4.93 4 0.0034 0.017 5.37 1.66 13.4
MP:0001787 pericardial edema 99 5 4.88 3.97 0.0035 0.017 5.31 1.65 13.3
MP:0013504 increased embryonic tissue cell apoptosis 142 6 4.08 3.79 0.0035 0.017 4.43 1.56 10.3
MP:0001674 abnormal germ layer development 143 6 4.06 3.76 0.0036 0.017 4.4 1.55 10.2
MP:0002998 abnormal bone remodeling 191 7 3.54 3.63 0.0036 0.017 3.85 1.48 8.42
MP:0009698 heart hemorrhage 62 4 6.24 4.23 0.0038 0.018 6.84 1.77 19
MP:0008932 abnormal embryonic tissue physiology 301 9 2.89 3.41 0.0039 0.018 3.15 1.38 6.34
MP:0002747 abnormal aortic valve morphology 63 4 6.14 4.18 0.004 0.019 6.72 1.74 18.7
MP:0010429 abnormal heart left ventricle outflow tract morphology 63 4 6.14 4.18 0.004 0.019 6.72 1.74 18.7
MP:0000109 abnormal parietal bone morphology 64 4 6.04 4.14 0.0043 0.019 6.61 1.71 18.4
MP:0004016 decreased bone mass 103 5 4.69 3.85 0.0042 0.019 5.09 1.58 12.7
MP:0004986 abnormal osteoblast morphology 148 6 3.92 3.66 0.0042 0.019 4.24 1.49 9.83
MP:0002896 abnormal bone mineralization 196 7 3.45 3.55 0.0041 0.019 3.74 1.44 8.18
MP:0001120 abnormal uterus morphology 197 7 3.43 3.53 0.0042 0.019 3.72 1.44 8.14
MP:0003232 abnormal forebrain development 247 8 3.13 3.47 0.004 0.019 3.4 1.41 7.11
MP:0001175 abnormal lung morphology 613 14 2.21 3.16 0.004 0.019 2.45 1.27 4.37
MP:0002429 abnormal blood cell morphology/development 1106 21 1.84 3.03 0.0039 0.019 2.09 1.22 3.44
MP:0001622 abnormal vasculogenesis 65 4 5.95 4.09 0.0045 0.02 6.5 1.68 18.1
MP:0000282 abnormal interatrial septum morphology 104 5 4.65 3.82 0.0044 0.02 5.04 1.56 12.6
MP:0004148 increased compact bone thickness 33 3 8.79 4.58 0.0047 0.021 9.84 1.89 32.5
MP:0001139 abnormal vagina morphology 66 4 5.86 4.05 0.0048 0.021 6.39 1.65 17.8
MP:0009398 abnormal skeletal muscle fiber size 151 6 3.84 3.6 0.0047 0.021 4.15 1.46 9.62
MP:0002792 abnormal retinal vasculature morphology 152 6 3.82 3.58 0.0048 0.021 4.13 1.45 9.55
MP:0000920 abnormal myelination 200 7 3.38 3.48 0.0046 0.021 3.66 1.41 8.01
MP:0003921 abnormal heart left ventricle morphology 310 9 2.81 3.31 0.0047 0.021 3.05 1.34 6.14
MP:0004087 abnormal muscle fiber morphology 429 11 2.48 3.21 0.0046 0.021 2.71 1.3 5.15
MP:0000313 abnormal cell death 1427 25 1.69 2.91 0.0046 0.021 1.95 1.18 3.13
MP:0004783 abnormal cardinal vein morphology 34 3 8.53 4.5 0.0051 0.022 9.52 1.83 31.3
MP:0002417 abnormal megakaryocyte morphology 107 5 4.52 3.74 0.0049 0.022 4.89 1.52 12.2
MP:0005592 abnormal vascular smooth muscle morphology 108 5 4.47 3.71 0.0051 0.022 4.84 1.5 12.1
MP:0003229 abnormal vitelline vasculature morphology 205 7 3.3 3.41 0.0053 0.022 3.57 1.38 7.8
MP:0003755 abnormal palate morphology 315 9 2.76 3.25 0.0052 0.022 3 1.32 6.04
MP:0001846 increased inflammatory response 1058 20 1.83 2.92 0.0052 0.022 2.06 1.19 3.43
MP:0000729 abnormal myogenesis 68 4 5.69 3.96 0.0053 0.023 6.19 1.6 17.2
MP:0005006 abnormal osteoblast physiology 69 4 5.6 3.92 0.0056 0.023 6.1 1.58 16.9
MP:0013500 abnormal fibroblast apoptosis 69 4 5.6 3.92 0.0056 0.023 6.1 1.58 16.9
MP:0009657 failure of chorioallantoic fusion 69 4 5.6 3.92 0.0056 0.023 6.1 1.58 16.9
MP:0000285 abnormal heart valve morphology 157 6 3.69 3.48 0.0057 0.023 3.99 1.4 9.22
MP:0000164 abnormal cartilage development 207 7 3.27 3.37 0.0055 0.023 3.53 1.36 7.72
MP:0004264 abnormal extraembryonic tissue physiology 317 9 2.74 3.23 0.0054 0.023 2.98 1.31 6
MP:0009208 abnormal female genitalia morphology 441 11 2.41 3.1 0.0057 0.023 2.63 1.26 5
MP:0003861 abnormal nervous system development 1215 22 1.75 2.87 0.0056 0.023 1.99 1.17 3.26
MP:0000233 abnormal blood flow velocity 36 3 8.05 4.34 0.006 0.024 8.94 1.72 29.3
MP:0002658 abnormal liver regeneration 36 3 8.05 4.34 0.006 0.024 8.94 1.72 29.3
MP:0002187 abnormal fibula morphology 70 4 5.52 3.88 0.0059 0.024 6 1.56 16.6
MP:0004754 abnormal kidney collecting duct morphology 71 4 5.45 3.84 0.0062 0.024 5.91 1.53 16.4
MP:0000565 oligodactyly 71 4 5.45 3.84 0.0062 0.024 5.91 1.53 16.4
MP:0002110 abnormal digit morphology 322 9 2.7 3.18 0.006 0.024 2.93 1.28 5.9
MP:0000163 abnormal cartilage morphology 382 10 2.53 3.12 0.006 0.024 2.75 1.26 5.37
MP:0003727 abnormal retinal layer morphology 442 11 2.41 3.1 0.0058 0.024 2.63 1.25 4.99
MP:0001119 abnormal female reproductive system morphology 444 11 2.39 3.08 0.006 0.024 2.61 1.25 4.97
MP:0005193 abnormal anterior eye segment morphology 506 12 2.29 3.06 0.0058 0.024 2.51 1.24 4.66
MP:0013660 abnormal bone marrow hematopoietic cell morphology 113 5 4.28 3.58 0.0062 0.025 4.62 1.43 11.5
MP:0010425 abnormal heart and great vessel attachment 213 7 3.18 3.29 0.0065 0.025 3.43 1.32 7.48
MP:0010426 abnormal heart and great artery attachment 213 7 3.18 3.29 0.0065 0.025 3.43 1.32 7.48
MP:0004508 abnormal pectoral girdle bone morphology 267 8 2.9 3.21 0.0063 0.025 3.13 1.3 6.54
MP:0000572 abnormal autopod morphology 386 10 2.5 3.09 0.0064 0.025 2.72 1.25 5.31
MP:0003723 abnormal long bone morphology 580 13 2.17 2.97 0.0065 0.025 2.38 1.21 4.33
MP:0005370 liver/biliary system phenotype 1230 22 1.73 2.81 0.0064 0.025 1.96 1.16 3.21
MP:0004179 transmission ratio distortion 38 3 7.63 4.19 0.007 0.026 8.43 1.63 27.5
MP:0008189 increased transitional stage B cell number 38 3 7.63 4.19 0.007 0.026 8.43 1.63 27.5
MP:0008957 abnormal placenta junctional zone morphology 73 4 5.3 3.77 0.0068 0.026 5.74 1.49 15.9
MP:0002697 abnormal eye size 214 7 3.16 3.27 0.0066 0.026 3.41 1.32 7.45
MP:0002551 abnormal blood coagulation 270 8 2.86 3.18 0.0067 0.026 3.09 1.28 6.46
MP:0009676 abnormal hemostasis 272 8 2.84 3.15 0.007 0.026 3.07 1.27 6.41
MP:0000281 abnormal interventricular septum morphology 329 9 2.64 3.1 0.0069 0.026 2.86 1.26 5.76
MP:0011091 prenatal lethality, complete penetrance 390 10 2.48 3.05 0.0069 0.026 2.69 1.24 5.25
MP:0000783 abnormal forebrain morphology 1011 19 1.82 2.81 0.0069 0.026 2.04 1.16 3.42
MP:0005225 abnormal vertebrae development 74 4 5.22 3.73 0.0071 0.027 5.66 1.47 15.6
MP:0005048 abnormal thrombosis 117 5 4.13 3.48 0.0072 0.027 4.45 1.38 11.1
MP:0006032 abnormal ureteric bud morphology 75 4 5.16 3.69 0.0075 0.028 5.58 1.45 15.4
MP:0006055 abnormal vascular endothelial cell morphology 75 4 5.16 3.69 0.0075 0.028 5.58 1.45 15.4
MP:0003385 abnormal body wall morphology 119 5 4.06 3.44 0.0077 0.028 4.37 1.36 10.9
MP:0002413 abnormal megakaryocyte progenitor cell morphology 119 5 4.06 3.44 0.0077 0.028 4.37 1.36 10.9
MP:0002962 increased urine protein level 167 6 3.47 3.3 0.0076 0.028 3.73 1.32 8.63
MP:0000157 abnormal sternum morphology 220 7 3.08 3.19 0.0077 0.028 3.31 1.28 7.23
MP:0000134 abnormal compact bone thickness 120 5 4.03 3.41 0.008 0.029 4.33 1.35 10.8
MP:0004945 abnormal bone resorption 77 4 5.02 3.62 0.0082 0.03 5.42 1.41 15
MP:0003109 short femur 121 5 3.99 3.39 0.0083 0.03 4.29 1.34 10.7
MP:0003105 abnormal heart atrium morphology 224 7 3.02 3.13 0.0084 0.03 3.25 1.25 7.09
MP:0000787 abnormal telencephalon morphology 808 16 1.91 2.78 0.0083 0.03 2.12 1.15 3.68
MP:0020040 decreased bone ossification 41 3 7.07 3.98 0.0086 0.031 7.76 1.51 25.1
MP:0003227 abnormal vascular branching morphogenesis 41 3 7.07 3.98 0.0086 0.031 7.76 1.51 25.1
MP:0000116 abnormal tooth development 78 4 4.96 3.59 0.0086 0.031 5.35 1.39 14.7
MP:0013503 abnormal embryonic tissue cell apoptosis 172 6 3.37 3.21 0.0087 0.031 3.62 1.28 8.36
MP:0010630 abnormal cardiac muscle tissue morphology 342 9 2.54 2.97 0.0087 0.031 2.75 1.21 5.53
MP:0008102 lymph node hyperplasia 42 3 6.9 3.92 0.0092 0.032 7.56 1.47 24.5
MP:0003734 abnormal retinal inner plexiform layer morphology 42 3 6.9 3.92 0.0092 0.032 7.56 1.47 24.5
MP:0002699 abnormal vitreous body morphology 80 4 4.83 3.52 0.0093 0.032 5.21 1.36 14.3
MP:0001701 incomplete embryo turning 80 4 4.83 3.52 0.0093 0.032 5.21 1.36 14.3
MP:0005241 abnormal retinal ganglion layer morphology 124 5 3.9 3.32 0.0091 0.032 4.18 1.3 10.4
MP:0003797 abnormal compact bone morphology 174 6 3.33 3.18 0.0092 0.032 3.58 1.26 8.25
MP:0020202 abnormal macrophage cell number 285 8 2.71 3 0.0092 0.032 2.92 1.21 6.09
MP:0011182 decreased hematopoietic cell number 1508 25 1.6 2.61 0.0093 0.032 1.83 1.11 2.93
MP:0001183 overexpanded pulmonary alveoli 43 3 6.74 3.86 0.0098 0.033 7.37 1.43 23.8
MP:0005220 abnormal exocrine pancreas morphology 81 4 4.77 3.49 0.0098 0.033 5.14 1.34 14.1
MP:0000107 abnormal frontal bone morphology 81 4 4.77 3.49 0.0098 0.033 5.14 1.34 14.1
MP:0000130 abnormal trabecular bone morphology 288 8 2.68 2.97 0.0098 0.033 2.89 1.2 6.03
MP:0012382 abnormal blood cell physiology 1515 25 1.59 2.59 0.0099 0.033 1.82 1.1 2.92
MP:0002160 abnormal reproductive system morphology 1278 22 1.66 2.61 0.01 0.034 1.88 1.11 3.07
MP:0006027 impaired lung alveolus development 44 3 6.59 3.8 0.01 0.035 7.19 1.4 23.2
MP:0011339 abnormal glomerular mesangium morphology 83 4 4.66 3.42 0.011 0.035 5.01 1.3 13.8
MP:0008188 abnormal transitional stage B cell morphology 83 4 4.66 3.42 0.011 0.035 5.01 1.3 13.8
MP:0002132 abnormal respiratory system morphology 901 17 1.82 2.66 0.01 0.035 2.02 1.12 3.46
MP:0010487 abnormal right subclavian artery morphology 45 3 6.44 3.74 0.011 0.036 7.02 1.37 22.6
MP:0009395 increased nucleated erythrocyte cell number 45 3 6.44 3.74 0.011 0.036 7.02 1.37 22.6
MP:0002746 abnormal semilunar valve morphology 84 4 4.6 3.39 0.011 0.036 4.95 1.29 13.6
MP:0010224 abnormal heart ventricle outflow tract morphology 84 4 4.6 3.39 0.011 0.036 4.95 1.29 13.6
MP:0005253 abnormal eye physiology 483 11 2.2 2.77 0.011 0.036 2.39 1.14 4.53
MP:0000703 abnormal thymus morphology 551 12 2.11 2.73 0.011 0.036 2.29 1.13 4.25
MP:0000203 abnormal circulating aspartate transaminase level 131 5 3.69 3.17 0.011 0.037 3.95 1.23 9.8
MP:0011706 abnormal fibroblast migration 46 3 6.3 3.69 0.012 0.038 6.85 1.34 22
MP:0009458 abnormal skeletal muscle size 86 4 4.5 3.33 0.012 0.038 4.82 1.26 13.2
MP:0003141 cardiac fibrosis 183 6 3.17 3.03 0.012 0.038 3.39 1.2 7.82
MP:0003920 abnormal heart right ventricle morphology 183 6 3.17 3.03 0.012 0.038 3.39 1.2 7.82
MP:0005425 increased macrophage cell number 183 6 3.17 3.03 0.012 0.038 3.39 1.2 7.82
MP:0004982 abnormal osteoclast morphology 184 6 3.15 3.01 0.012 0.038 3.37 1.19 7.78
MP:0005029 abnormal amnion morphology 47 3 6.17 3.63 0.013 0.039 6.7 1.31 21.5
MP:0004969 pale kidney 47 3 6.17 3.63 0.013 0.039 6.7 1.31 21.5
MP:0002748 abnormal pulmonary valve morphology 47 3 6.17 3.63 0.013 0.039 6.7 1.31 21.5
MP:0012397 abnormal nucleated erythrocyte cell number 47 3 6.17 3.63 0.013 0.039 6.7 1.31 21.5
MP:0002824 abnormal chorioallantoic fusion 87 4 4.44 3.3 0.012 0.039 4.77 1.24 13.1
MP:0009404 centrally nucleated skeletal muscle fibers 88 4 4.39 3.27 0.013 0.04 4.71 1.23 12.9
MP:0002989 small kidney 243 7 2.78 2.88 0.013 0.04 2.98 1.15 6.5
MP:0000959 abnormal somatic sensory system morphology 702 14 1.93 2.61 0.013 0.04 2.11 1.1 3.77
MP:0010995 abnormal lung alveolus development 48 3 6.04 3.58 0.013 0.041 6.55 1.28 21
MP:0009347 increased trabecular bone thickness 48 3 6.04 3.58 0.013 0.041 6.55 1.28 21
MP:0011521 decreased placental labyrinth size 48 3 6.04 3.58 0.013 0.041 6.55 1.28 21
MP:0013501 increased fibroblast apoptosis 48 3 6.04 3.58 0.013 0.041 6.55 1.28 21
MP:0006386 absent somites 48 3 6.04 3.58 0.013 0.041 6.55 1.28 21
MP:0000547 short limbs 136 5 3.55 3.07 0.013 0.041 3.8 1.18 9.41
MP:0000559 abnormal femur morphology 189 6 3.07 2.94 0.013 0.041 3.28 1.16 7.55
MP:0001513 limb grasping 246 7 2.75 2.84 0.014 0.041 2.94 1.14 6.41
MP:0009209 abnormal internal female genitalia morphology 432 10 2.24 2.69 0.014 0.041 2.41 1.11 4.7
MP:0005406 abnormal heart size 705 14 1.92 2.6 0.013 0.041 2.1 1.09 3.75
MP:0000218 increased leukocyte cell number 1080 19 1.7 2.5 0.014 0.041 1.89 1.07 3.17
MP:0001845 abnormal inflammatory response 1235 21 1.64 2.48 0.014 0.041 1.84 1.07 3.03
MP:0000217 abnormal leukocyte cell number 1718 27 1.52 2.44 0.014 0.041 1.73 1.06 2.75
MP:0004134 abnormal chest morphology 49 3 5.92 3.53 0.014 0.042 6.4 1.25 20.5
MP:0000133 abnormal long bone metaphysis morphology 49 3 5.92 3.53 0.014 0.042 6.4 1.25 20.5
MP:0002192 hydrops fetalis 90 4 4.3 3.21 0.014 0.042 4.6 1.2 12.6
MP:0010468 abnormal thoracic aorta morphology 139 5 3.48 3.01 0.014 0.043 3.71 1.16 9.19
MP:0005327 abnormal mesangial cell morphology 50 3 5.8 3.48 0.015 0.044 6.27 1.23 20
MP:0003856 abnormal hindlimb stylopod morphology 194 6 2.99 2.86 0.015 0.044 3.19 1.13 7.35
MP:0002398 abnormal bone marrow cell morphology/development 575 12 2.02 2.57 0.015 0.044 2.19 1.08 4.06
MP:0002722 abnormal immune system organ morphology 1323 22 1.61 2.44 0.015 0.044 1.8 1.06 2.94
MP:0011181 increased hematopoietic cell number 1247 21 1.63 2.44 0.015 0.044 1.82 1.06 2.99
MP:0005244 hemopericardium 51 3 5.69 3.43 0.016 0.045 6.14 1.2 19.6
MP:0005599 increased cardiac muscle contractility 51 3 5.69 3.43 0.016 0.045 6.14 1.2 19.6
MP:0000297 abnormal atrioventricular cushion morphology 93 4 4.16 3.13 0.016 0.045 4.44 1.16 12.2
MP:0008056 abnormal retinal ganglion cell morphology 93 4 4.16 3.13 0.016 0.045 4.44 1.16 12.2
MP:0000165 abnormal long bone hypertrophic chondrocyte zone 141 5 3.43 2.97 0.015 0.045 3.65 1.14 9.05
MP:0001297 microphthalmia 195 6 2.97 2.85 0.015 0.045 3.17 1.12 7.31
MP:0000074 abnormal neurocranium morphology 252 7 2.68 2.77 0.015 0.045 2.87 1.11 6.25
MP:0008469 abnormal protein level 1092 19 1.68 2.45 0.015 0.045 1.86 1.06 3.13
MP:0002633 persistent truncus arteriosis 94 4 4.11 3.1 0.016 0.046 4.39 1.15 12
MP:0002356 abnormal spleen red pulp morphology 143 5 3.38 2.93 0.016 0.046 3.6 1.12 8.92
MP:0010650 abnormal aorticopulmonary septum morphology 95 4 4.07 3.07 0.017 0.047 4.34 1.13 11.9
MP:0010651 aorticopulmonary septal defect 95 4 4.07 3.07 0.017 0.047 4.34 1.13 11.9
MP:0003942 abnormal urinary system development 144 5 3.36 2.91 0.017 0.047 3.57 1.12 8.85
MP:0000245 abnormal erythropoiesis 144 5 3.36 2.91 0.017 0.047 3.57 1.12 8.85
MP:0000759 abnormal skeletal muscle morphology 445 10 2.17 2.59 0.016 0.047 2.34 1.08 4.55
MP:0000849 abnormal cerebellum morphology 445 10 2.17 2.59 0.016 0.047 2.34 1.08 4.55
MP:0011519 abnormal placenta labyrinth size 53 3 5.47 3.34 0.017 0.048 5.89 1.15 18.8
MP:0003395 abnormal subclavian artery morphology 53 3 5.47 3.34 0.017 0.048 5.89 1.15 18.8
MP:0003409 decreased width of hypertrophic chondrocyte zone 53 3 5.47 3.34 0.017 0.048 5.89 1.15 18.8
MP:0008250 abnormal myeloid leukocyte morphology 950 17 1.73 2.43 0.017 0.048 1.9 1.05 3.26
MP:0000952 abnormal CNS glial cell morphology 320 8 2.42 2.64 0.018 0.049 2.58 1.07 5.38
MP:0011504 abnormal limb long bone morphology 450 10 2.15 2.55 0.018 0.049 2.31 1.06 4.5
MP:0008528 polycystic kidney 54 3 5.37 3.29 0.018 0.05 5.77 1.13 18.4
MP:0010403 atrial septal defect 97 4 3.99 3.02 0.018 0.05 4.25 1.11 11.6
MP:0005165 increased susceptibility to injury 147 5 3.29 2.86 0.018 0.05 3.5 1.09 8.66
MP:0001625 cardiac hypertrophy 202 6 2.87 2.75 0.018 0.05 3.06 1.08 7.04
